Tumor containment: a more general mathematical analysis
- 6 March 2024
- journal article
- research article
- Published by Springer Nature in Journal of Mathematical Biology
- Vol. 88 (4) , 1-29
Abstract
Clinical and pre-clinical data suggest that treating some tumors at a mild, patient-specific dose might delay resistance to treatment and increase survival time. A recent mathematical model with sensitive and resistant tumor cells identified conditions under which a treatment aiming at tumor containment rather than eradication is indeed optimal. This model however neglected mutations from sensitive to resistant cells, and assumed that the growth-rate of sensitive cells is non-increasing in the size of the resistant population. The latter is not true in standard models of chemotherapy. This article shows how to dispense with this assumption and allow for mutations from sensitive to resistant cells. This is achieved by a novel mathematical analysis comparing tumor sizes across treatments not as a function of time, but as a function of the resistant population size.Keywords
Funding Information
- HORIZON EUROPE Marie Sklodowska-Curie Actions (754362, 955708)
This publication has 36 references indexed in Scilit:
- Stability and reachability analysis for a controlled heterogeneous population of cellsOptimal Control Applications and Methods, 2020
- Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanomaEBioMedicine, 2019
- Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancerJournal of Theoretical Biology, 2018
- Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapyJournal de Mathématiques Pures et Appliquées, 2018
- Spatial competition constrains resistance to targeted cancer therapyNature Communications, 2017
- Optimization of an in vitro chemotherapy to avoid resistant tumoursJournal of Theoretical Biology, 2017
- A change of strategy in the war on cancerNature, 2009
- Modelling chemotherapy resistance in palliation and failed cureJournal of Theoretical Biology, 2008
- Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapyMathematical Biosciences, 1992
- Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cellsMathematical Biosciences, 1992